ClinicalTrials.Veeva

Menu
K

Kannarr Eye Care | Kannarr Eye Care - Pittsburg, KS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AGN-190584
Perfluorohexyloctane
Pilocarpine HCl
Povidone
Latanoprost
PVP
Omega 3 fatty acid
Tavilermide
AKB-9778
Iodine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 66 total trials

A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease

Dry Eye Disease (DED) refers to a long-term condition that happens when there is not enough lubrication in your eyes. This can happen when your eye c...

Enrolling
Dry Eye Disease
Drug: ABBV-444
Drug: REFRESH OPTIVE UD

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Comb...

Enrolling
Dry Eye Disease
Drug: Vehicle
Drug: Lifitegrast/Perfluorohexyloctane Fixed Dose Combination

Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and e...

Active, not recruiting
Juvenile Myopia
Device: Novel spectacle lens design
Device: Spectacle lenses

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficac...

Active, not recruiting
Myopia
Juvenile Myopia
Device: Novel spectacle lens design
Device: Spectacle lenses

This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will...

Enrolling
Myopia
Myopia Progression
Device: Single vision, impact-resistant spectacle lenses; Test Arm
Device: Single vision, impact-resistant spectacle lenses; Control Arm

The purpose of this post-approval study is to confirm the effectiveness of the MiSight 1 Day lens in clinical practices within the US and to assess t...

Enrolling
Myopia
Device: Proclear 1 day
Device: MiSight 1 Day

To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses.To qu...

Active, not recruiting
Myopia
Myopia Progression
Device: Spectacle Lenses

The goal of this clinical trial is to learn if Phentolamine Ophthalmic Solution works to treat adults that have had keratorefractive surgery and have...

Enrolling
Vision Loss Night
Vision Disorders
Drug: 0.75% Phentolamine Ophthalmic Solution
Drug: Placebo

This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angl...

Active, not recruiting
Open Angle Glaucoma
Ocular Hypertension
Drug: Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution
Drug: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution

This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects wil...

Active, not recruiting
Myopia
Myopia Progression
Device: Spectacle lenses
Device: Novel spectacle lens design

This is a prospective, randomized, double-masked, multi-site clinical trial designed to compare the efficacy of SYSTANE® PRO (Alcon Laboratories, Inc...

Not yet enrolling
Dry Eye Disease (DED)
Drug: MIEBO™ (Perfluorohexyloctane, PFHO)
Drug: SYSTANE® PRO

Trial sponsors

Johnson & Johnson (J&J) logo
Alcon logo
CooperVision logo
S
Allergan logo
AbbVie logo
Ocuphire Pharma logo
Shire logo
A
Bausch + Lomb logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems